EZH2 knockdown in tamoxifen-resistant MCF-7 cells unravels novel targets for regaining sensitivity towards tamoxifen.

CONCLUSION: Overall, we propose that targeting EZH2 or the molecules down the cascade might be helpful in reacquiring sensitivity to tamoxifen in breast cancer. PMID: 32990923 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32990923?dopt=Abstract

Source: Breast Cancer - September 28, 2020 Category: Cancer & Oncology Authors: Kumari K, Kumar S, Parida DK, Mishra SK Tags: Breast Cancer Source Type: research